INTRODUCTION
T hree major metabolic abnormalities contribute to the development of hyperglycemia in Type 2 diabetes mellitus such as impaired insulin secretion in response to glucose, increased hepatic glucose production and decreased insulinstimulated glucose uptake in peripheral tissues. Th e latter 2 abnormalities are primarily due to insulin resistance (1, 2) . Non insulin dependent diabetic mellitus has also been associated with an increased risk for premature arteriosclerosis due to increase in triglycerides and low density lipoprotein levels. About 70-80% of deaths in diabetic patients are due to vascular diseases. An ideal treatment for diabetes would be a drug that not only controls the glycemic level but also prevent the development of arteriosclerosis and other complication of diabetes.
Cardiovascular disease is one of the leading causes of death in the western world and diabetes mellitus has been identifi ed as a primary risk factor (3), due to (4) . Hypertension, a component of metabolic/insulin resistance syndrome, is an important risk factor for cardiovascular disease contributing to the increased morbidity and mortality. Oxidative stress and glucose has emerged as an important pathogenic factor in the development of hypertension.
ABSTRACT: Present study was designed to evaluate effect Hesperidin on Cardiovascular Complication in isoproterenol induced myocardial infarction in normal and Streptozotocin-Nicotinamide induced in diabetic rats. Hesperidin (100 mg/kg, p.o) was administered for 28 days in rats injected with single dose of Streptozotocin (65 mg/kg, i.p, STZ) and Nicotinamide (110 mg/kg, i.p, NIC) and after isoproterenol (200 mg/kg, s.c.) induced myocardial infarction in rats on
Reactive oxygen species may contribute to the events of atherogenesis and leading to the progression of atherogenic lesions by promoting oxidation of low density lipoproteins (5) . Isoproterenol has been found to cause a severe stress in the myocardium resulting in infarct like necrosis of heart muscles. It also increases the level of serum and myocardial lipids (6) and also increases the level of cholesterol in the tissues which in turn leads to coronary heart disease (7) .
Long before the use of insulin became common, indigenous remedies were used for the treatment of diabetes mellitus and hyperlipidemia. Th ere has been an increasing demand from patients for the use of natural products with antidiabetic and antihyperlipidemia and impairment of hepatic and other body functions. Th e undesirable side eff ect and contraindications of synthetic drugs, and the fact that they are not suitable for use during pregnancy, have made scientists look towards hypoglycemia agents of plant origin. Many herb antihyperglycemia and antihyperlipidemia actions.
Hesperidin (HES) is an abundant and inexpensive byproduct of Citrus cultivation and isolated from the ordinary orange Citrus aurantium and other species of the genus Citrus (family: Rutaceae). It is reported to have anti-allergic, radio protective, immunomodulator, anti-hypertensive and antioxidant properties. When Hesperidin is administered orally, it is hydrolyzed by intestinal micro fl ora to yield a major active metabolite Hesperidin.
Literature survey showed that, there was no report regarding the eff ect of HES on glucose, HbA1c, lipid parameter and lipid metabolizing enzymes in isoproterenol induced myocardial infarction in normal and Streptozotocin-Nicotinamide induced in diabetic rats. Hence, the purpose of the present study was to instigate the eff ect Hesperidin on serum glucose, HbA1c, lipid parameter and lipid metabolizing enzymes in isoproterenol induced myocardial infarction in normal and StreptozotocinNicotinamide induced in diabetic rats.
MATERIALS AND METHOD

Drugs and Chemicals
Hesperidin was obtained from ACROS Lab, US. STZ and NIC were obtained from SIGMA, St. Louis, MO, USA. All other chemicals and reagents used in the study were of analytical grade.
Experimental Animals
All experiments and protocols described in present study were approved by the Institutional Animal Ethics Committee (IAEC) of Dharmaj Degree Pharmacy College, Anand. Sprague Dawley rats (205 ± 15 g) were housed in-group of 3 animals per cage and maintained under standardized laboratory conditions (12-h light/dark cycle, 24°C) and provided free access to palleted CHAKKAN diet (Nav Maharashtra Oil Mills Pvt., Pune) and purifi ed drinking water ad libitium.
Experimental Induction of Type 2 Diabetes in Rats
Type 2 Diabetes was induced in rats by a single intraperitoneal (i.p) injection of Streptozotocin (65 mg/kg, STZ) in overnight fasting rats or mice followed by the i.p administration of Nicotinamide (110 mg/kg, NIC) after 15 minutes. STZ was dissolved in citrate buff er (pH 4.5) and NIC was dissolved in normal saline. After 7 days following STZ and NIC administration, blood was collected from retro-orbital puncture and serum samples were analyzed for blood glucose (8) . Animals showing fasting blood glucose higher than 300 mg/dL were considered as diabetic and used for the further study.
Experimental Protocol
Animals were divided into following groups, each group containing 6 animals and the treatment period for whole study was 4 weeks. 
BIOCHEMICAL ESTIMATIONS Characterization of Type 2 Diabetes Model
Type 2 diabetes was confi rmed by measuring fasting serum glucose using standard diagnostic kit (SPAN diagnostics Pvt., India) and the degree of uncontrolled diabetic state was confi rmed by measuring HbA1c (Ion Exchange Resin method). After 4 weeks, diabetes was confi rmed by measuring glucose and HbA1c as mentioned above.
Estimation of Serum Markers
On 4 th week blood samples were collected from retro-orbital plexus under light ether anesthesia and centrifuged at 2500 rpm for 20 minutes to separate serum. Glucose, HbA1c, TC, TG, HDL and LDL were estimated using diagnostic kits (SPAN Diagnostics Pvt. India). Th e activities of lipid metabolizing enzymes such as cholesterol ester synthetase (CES), lecithin: Cholesterol acyl transferase (LCAT) and lipoprotein lipase (LPL) were determined from the heart tissues sample as suggested by Kothari et al (9), Hitz et al (10) and Slater et al (11) .
Measurement of systolic and diastolic blood pressure
Systolic and diastolic blood pressure was measured indirectly in a conscious, pre-warmed, and slightly restrained rat by tail cuff method (Harvard rat-tail blood pressure monitor, USA). An average of eight consecutive reading was noted after completion of myocardial infarction in normal and STZ-NIC induced diabetic rats.
Statistical Analysis
All of the data are expressed as mean ± SEM. Statistical signifi cance between more than two groups was tested using one-way ANOVA followed by the Bonferroni multiple comparisons test or unpaired two-tailed student's t-test as appropriate using a computer-based fi tting program (Prism, Graphpad 5). Diff erences were considered to be statistically signifi cant when p<0.05.
RESULTS
CHARACTERIZATION OF TYPE 2 DIABETES
Single intraperitoneal (i.p) injection of Streptozotocin (65 mg/kg) followed by i.p administration of Nicotinamide (1100 mg/kg) to rats produced severe hyperglycemia and increased HbAc in 70 to 80% the animals.
EFFECT OF HES ON SERUM ENZYMES
Th ere was a signifi cant (p<0.001) increase in blood glucose and HbA1c level of STZ-NIC injected animals compared to ND-CON group (Fig. 1) . Serum total cholesterol, LDL and triglyceride were signifi cant (p<0.001) increase in STZ-NIC diabetic rats as compared to non-diabetic rats. Administration of HES in STZ-NIC diabetic rats (D-HES) signifi cant (p<0.05) decrease on blood glucose and HbA1c, while it signifi cantly signifi cant (p<0.01) reduced serum total cholesterol, triglyceride and LDL (p< 0.01) in D-HES group as compared to D-CON group but there was no signifi cant changes in the levels of HDL (Fig. 2) .
Effect of HES on Lipid Metabolizing Enzymes enzyme
Th ere was a signifi cant (p<0.001) increase in CES after myocardial infarction in D-CON group as compared to ND-CON group (Fig. 3) . Treatment of HES signifi cant (p<0.05) decrease levels of CES as compared to diabetic rats. Th ere was a signifi cant (p<0.001, p<0.001) increase in LCAT and LPL after myocardial infarction in D-CON group as compared to respective ND-CON group (Fig. 3) . Treatment of HES and NOB in diabetic rats signifi cant (p<0.05) decrease levels of LCAT and LPL.
Effect of Hesperidin on systolic and diastolic blood pressure
Th ere was a signifi cant (p<0.01) increase in systolic and diastolic blood pressure after myocardial infarction in D-CON group as compared to ND-CON group (Fig. 4) . Treatment of HES in STZ-NIC diabetic rats (D-HES) signifi cant (p<0.05) decrease levels of systolic and diastolic blood pressure as compared to diabetic control (Fig. 4) . 
C)
Values are expressed as mean ± SEM for six animals in the group. * P<0.05, **P<0.01, ***P<0.001 considered statistically signifi cant as compared to respective Control group. Values are expressed as mean ± SEM for six animals in the group. * P<0.05, ** P<0.01, *** P<0.001 considered statistically signifi cant as compared to respective Control group.
DISCUSSION
Th e present study was under taken with the objective of exploring the Hesperidin on lipid profi le, diabetic marker and Lipid Metabolizing Enzymes experimentally induced myocardial infarction in diabetic rats. Diabetes mellitus is a chronic disorder caused by partial or complete insulin defi ciency, which produces inadequate glucose control and leads to chronic complication. Premature and extensive arteriosclerosis involving renal, peripheral, and cardiovascular vessels remain the major complication of diabetes mellitus. Alteration in the serum lipid profi le is known to occur in diabetes and this is likely to increase the risk for coronary heart disease. A reduction in serum lipids, particularly of the LDL and VLDL fraction and TG, should be considered as being benefi cial for the long term prognosis of these patients. Lower of blood glucose and plasma lipid levels thought dietary modifi cation and drug therapy seem to be associated with a decrease in the risk of vascular disease.
Recent studies have suggested that prevalence of type 2 diabetes is rapidly increasing. Patients with diabetes show an increased mortality concerning cardiovascular events. Th ey more often suff er from myocardial infarction as non-diabetics mostly with a more serious course. Moreover, the post-infarction course is aff ected with a worse prognosis as in nondiabetics (12) .
In the present study, an increase in the levels of serum glucose and HbA1c in STZ-NIC treated rats confi rmed the induction of diabetes mellitus. Signifi cant decrease was observed in the glucose and HbA1c level in diabetic rats after treatment with HES (100 mg/kg) when compared with D-CON rats at the end of experimental period. STZ causes diabetes by the rapid depletion of β-cells and thereby brings about a reduction in insulin release. HbA1c level has been reported to be increased in patients with diabetes mellitus (13) . It was reported that during diabetes mellitus, the excess of glucose present in the blood reacts with hemoglobin to form HbA1c (14) . Th e level of HbA1c is always monitered as a reliable index of glycemic control in diabetes (15) . Elevated levels of HbA1c observed in our study reveal that diabetes animals had prior high blood glucose level.
Lipids play an important role in cardiovascular disease, by modifying the composition, structure and stability of cell membranes. Altered lipid metabolism is considered to accelerate the development of atherosclerosis, a major risk factor in myocardial infarction. High levels of circulating cholesterol and its accumulation in heart tissue is well associated with cardiovascular damage (11) . In the present study there was a signifi cant decrease in cardiac LCAT and LPL activity whereas a signifi cant increase in the activity of CES was found in ISO intoxicated rats. HDL is the main substrate for LCAT for cholesterol esterifi cation and incorporation (16) .
Hypertension is a risk factor for the development and worsening of many diabetes complications, and likewise having diabetes increases your risk of developing high blood pressure. Th e risk of a recurrent myocardial infarction decreases with strict blood pressure. In the present study there was a signifi cant increase in systolic and diastolic blood pressure activity in ISO intoxicated diabetic rats compared to control diabetic rats. Treatment with HES was signifi cantly decreased in systolic and diastolic blood pressure activity in experimentally induced myocardial infarction in diabetic rats as compared to control diabetic rats.
A signifi cant increase in the level of LCAT in diabetic rats treated with HES. In the present study hypertriglyceridemia observed in ISO intoxicated rats is due to decrease activity of LPL in the myocardium tissues. Accumulation of ester cholesterol occurs when the rate of esterifi cation by cholesterol ester synthetase exceeds the rate of hydrolysis, which in turn results in myocardial membrane damage (17) . HES alter the activities of LCAT, LPL and CES near to the Almost normal, indicating the potential lipid lowering eff ects of HES.
Th e chronic diabetic state was also associated with dyslipedemia. Th is study concluded that HES at 100 mg/kg may show some protection on glucose, HbA1c and more decreased lipid profi le, systolic and diastolic blood pressure and lipid metabolizing enzymes in experimentally induced myocardial infarction in diabetic rats. We concluded Hesperidin reduce cardiac complication in experimentally induced myocardial infarction in diabetic rats.
